Evidence map›Paper›PMID 19838703›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2009

EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.

Ozlem L Kapucu, Flavio Nobili, Andrea Varrone, Jan Booij, Thierry Vander Borght, Kjell Någren, Jacques Darcourt, Klaus Tatsch, Koen J Van Laere

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Guideline
  2. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.European journal of nuclear medicine and molecular imaging · 2024
    Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. EANM perspectives for CZT SPECT in brain applications.European journal of nuclear medicine and molecular imaging · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 8 countries.

Ozlem L KapucuDepartment of Nuclear Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey. ozlemkapucu@gmail.com
Flavio Nobili
Andrea Varrone
Jan Booij
Thierry Vander Borght
Kjell Någren
Jacques Darcourt
Klaus Tatsch
Koen J Van Laere
Centre Antoine Lacassagne · FRGazi University · TRKarolinska Institutet · SEKU Leuven · BEOspedale Policlinico San Martino · ITRigshospitalet · DKStädtisches Klinikum Karlsruhe · DEUCLouvain · BEUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners when making recommendations, performing, interpreting, and reporting the results of brain perfusion single photon emission computed tomography (SPECT) studies using (99m)Tc-labelled radiopharmaceuticals. The aim is to achieve a high quality standard for brain perfusion SPECT imaging, which will increase the diagnostic impact of this technique in clinical practice. The present document replaces a former version of the guideline published in 2001 which was inspired by the Society of Nuclear Medicine Procedure Guideline for Brain Perfusion SPECT [1], the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines are intended to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.

Indexed as

Organotechnetium CompoundsRadiopharmaceuticalsSocietiesAdultBrainChildContraindicationsEuropeFemaleHumansImage Interpretation, Computer-AssistedNuclear MedicinePatient Care ManagementPerfusion ImagingPregnancyResearch ReportOrganotechnetium CompoundsRadiopharmaceuticals

Identifiers

PMID19838703
OpenAlexW2035264537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.